EYPT vs V · rev $1.2M vs P/E 33, rev $40.00B
Eyepoint Pharmaceuticals Inc (EYPT) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
EYPT currently screens at market cap $1.10B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the EYPT and V stock pages for the full models.
Not investment advice.